BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28554534)

  • 1. Ophthalmic Manifestations of Xeroderma Pigmentosum: A Perspective from the United Kingdom.
    Lim R; Sethi M; Morley AMS
    Ophthalmology; 2017 Nov; 124(11):1652-1661. PubMed ID: 28554534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular manifestations of xeroderma pigmentosum: long-term follow-up highlights the role of DNA repair in protection from sun damage.
    Brooks BP; Thompson AH; Bishop RJ; Clayton JA; Chan CC; Tsilou ET; Zein WM; Tamura D; Khan SG; Ueda T; Boyle J; Oh KS; Imoto K; Inui H; Moriwaki S; Emmert S; Iliff NT; Bradford P; Digiovanna JJ; Kraemer KH
    Ophthalmology; 2013 Jul; 120(7):1324-36. PubMed ID: 23601806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular surface biopsies of patients with xeroderma pigmentosum in the United Kingdom: a retrospective observational case series.
    Vekinis J; Morley AMS
    Br J Ophthalmol; 2021 Sep; 105(9):1222-1230. PubMed ID: 32892165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular manifestations of xeroderma pigmentosum at a tertiary eye care center in Saudi Arabia.
    Alfawaz AM; Al-Hussain HM
    Ophthalmic Plast Reconstr Surg; 2011; 27(6):401-4. PubMed ID: 21629134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular Features in a Large Cohort of Indians With Xeroderma Pigmentosum.
    Nandyala S; Mohamed A; Chaurasia S; Kaliki S; Ramappa M; Vemuganti GK
    Cornea; 2021 May; 40(5):571-577. PubMed ID: 33259350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular manifestations of trichothiodystrophy.
    Brooks BP; Thompson AH; Clayton JA; Chan CC; Tamura D; Zein WM; Blain D; Hadsall C; Rowan J; Bowles KE; Khan SG; Ueda T; Boyle J; Oh KS; DiGiovanna JJ; Kraemer KH
    Ophthalmology; 2011 Dec; 118(12):2335-42. PubMed ID: 21959366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep phenotyping of 89 xeroderma pigmentosum patients reveals unexpected heterogeneity dependent on the precise molecular defect.
    Fassihi H; Sethi M; Fawcett H; Wing J; Chandler N; Mohammed S; Craythorne E; Morley AM; Lim R; Turner S; Henshaw T; Garrood I; Giunti P; Hedderly T; Abiona A; Naik H; Harrop G; McGibbon D; Jaspers NG; Botta E; Nardo T; Stefanini M; Young AR; Sarkany RP; Lehmann AR
    Proc Natl Acad Sci U S A; 2016 Mar; 113(9):E1236-45. PubMed ID: 26884178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular and Periocular Tumors in Xeroderma Pigmentosum: A Study of 120 Asian Indian Patients.
    Kaliki S; Jajapuram SD; Maniar A; Mishra DK
    Am J Ophthalmol; 2019 Feb; 198():146-153. PubMed ID: 30336128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular surface squamous neoplasia in xeroderma pigmentosum: clinical spectrum and outcome.
    Gupta N; Sachdev R; Tandon R
    Graefes Arch Clin Exp Ophthalmol; 2011 Aug; 249(8):1217-21. PubMed ID: 21484462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of the genotypic and phenotypic spectrum of xeroderma pigmentosum in Chinese population.
    Zhang J; Cheng R; Yu X; Sun Z; Li M; Yao Z
    Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):58-63. PubMed ID: 27982466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients.
    Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G
    Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole Exome Sequencing allows the identification of two novel groups of Xeroderma pigmentosum in Tunisia, XP-D and XP-E: Impact on molecular diagnosis.
    Ben Rekaya M; Naouali C; Messaoud O; Jones M; Bouyacoub Y; Nagara M; Pippucci T; Jmel H; Chargui M; Jerbi M; Alibi M; Dallali H; Bashamboo A; McElreavey K; Romeo G; Barakat A; Zghal M; Yacoub-Youssef H; Abdelhak S
    J Dermatol Sci; 2018 Feb; 89(2):172-180. PubMed ID: 29169765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ophtalmologic manifestations of the xeroderma pigmentosum].
    Mseddi M; Sellami D; Elloumi Y; Aloulou Y; Kammoun B; Turki H; Feki J; Zahaf A
    Tunis Med; 2006 Sep; 84(9):542-4. PubMed ID: 17263199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ocular manifestations in xeroderma pigmentosum].
    Süsskind D; Berneburg M; Rohrbach JM
    Klin Monbl Augenheilkd; 2011 Mar; 228(3):239-44. PubMed ID: 20799158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
    Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ipsilateral presentation of ocular surface squamous neoplasia and conjunctival melanoma in xeroderma pigmentosum: A rare occurrence.
    Arya D; Das S; Gandhi A
    Indian J Ophthalmol; 2019 Dec; 67(12):2068-2071. PubMed ID: 31755462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional and molecular genetic analyses of nine newly identified XPD-deficient patients reveal a novel mutation resulting in TTD as well as in XP/CS complex phenotypes.
    Schäfer A; Gratchev A; Seebode C; Hofmann L; Schubert S; Laspe P; Apel A; Ohlenbusch A; Tzvetkov M; Weishaupt C; Oji V; Schön MP; Emmert S
    Exp Dermatol; 2013 Jul; 22(7):486-9. PubMed ID: 23800062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin cancers in patients of skin phototype V or VI with xeroderma pigmentosum type C (XP-C): A retrospective study.
    Ventéjou S; Bagny K; Waldmeyer J; Cartault F; Machet L; Osdoit S
    Ann Dermatol Venereol; 2019 Mar; 146(3):192-203. PubMed ID: 30853323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding Xeroderma Pigmentosum Complementation Groups Using Gene Expression Profiling after UV-Light Exposure.
    Bowden NA; Beveridge NJ; Ashton KA; Baines KJ; Scott RJ
    Int J Mol Sci; 2015 Jul; 16(7):15985-96. PubMed ID: 26184184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
    Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
    Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.